Investor Relations – 徐诺药业

1

Email : info@xynomicpharma.com

Facebook Twitter Google+ Skype Vimeo YouTube

Home
- Privacy Policy
- Expanded Access
Pipeline
Management
Media Center
Investor Relations
Contact Us
中文 (中国)

Investor Relations

Latest News

Y. Mark Xu talks with CGTN (China Global TV Network) 10/26/2018
Xynomic Pharma Receives Fast-Track Designation from the US FDA for Abexinostat as 4L Therapy Treating Follicular Lymphoma 09/26/2019
Xynomic Pharma Doses First Chinese Patient in Pivotal Phase 3 Kidney Cancer Trial and Hires Medical Monitor 09/26/2019
Xynomic Pharma Reports Encouraging Interim Data from Phase 1b Study of Abexinostat Combined with Keytruda® in Multiple Solid Tumors 09/26/2019
Xynomic Pharma Reports Encouraging Interim Data from Phase 1b Study of Abexinostat Combined with Keytruda® in Multiple Solid Tumors 09/01/2019

Address

United States: 3500 South DuPont Highway, Suite SS101, Dover, DE 19901, USA
China: Suite 3306, K. Wah Centre, 1010 Middle Huaihai Road, Shanghai 200031, China

Links

Career
Our Policies
Privacy Policy

Copyright © 2017 Xynomic Pharmaceuticals Holdings, Inc. All Rights Reserved.